Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population

Diabetic Medicine

Volumn 25, Issue 8, 2008, Pages 942-948

  Edge, J A ^a   James, T ^a   Shine, B ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Adolescence; Children; Lipids

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GREAT BRITAIN; HUMANS; LIPID METABOLISM; LIPIDS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 48149088145     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02518.x     Document Type: Article

References (21)

1. Libby P, Nathan DM, Abraham K, Brunzell JD, Fradkin JE, Haffner SM et al. Report of the National Heart, Lung, and Blood Institute - National Institute of Diabetes and Digestive and Kidney Diseases Working Group on cardiovascular complications of Type 1 diabetes mellitus. Circulation 2005 111 : 3489 3493.
2. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G et al. Risk factors for coronary heart disease in Type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 2004 27 : 530 537.
3. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. J Am Med Assoc 2003 290 : 2271 2276.
4. Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. J Am Med Assoc 2003 290 : 2277 2283.
5. McGill HC Jr, McMahon CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA et al. Associations of coronary heart disease risk factors with intermediate lesion of atherosclerosis in youth: the Pathobiologic Determinants of Atherosclerosis in Youth (PDAY) Research Group. Aterioscler Thromb Vasc Biol 2000 20 : 1998 2004.
6. McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007 115 : 1948 1967.
7. McMahan CA, Gidding SS, Fayad ZA, Zieske AW, Malcom GT, Tracy RE et al. Risk scores predict atherosclerotic lesions in young people. Arch Intern Med 2005 165 : 883 890.
8. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al. Mortality from heart disease in a cohort of 23 000 patients with insulin-treated diabetes. Diabetologia 2003 46 : 760 765.
9. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with Type 1 diabetes, 1990-1996. Arch Dis Child 1999 81 : 318 323.
10. Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ et al. Lipid abnormalities are prevalent in youth with Type 1 and Type 2 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2006 149 : 314 319.
11. Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK et al. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med 2007 161 : 159 165.
12. Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O et al. Spectrum and prevalence of atherogenic risk factors in 27 358 children, adolescents, and young adults with Type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006 29 : 218 225.
13. Maahs DM, Wadwa RP, McFann K, Nadeau K, Williams MR, Eckel RH et al. Longitudinal lipid screening and use of lipid-lowering medications in pediatric Type 1 diabetes. J Pediatr 2007 150 : 146 150.
14. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS2 Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005 91 : v1 v52.
15. NICE. Diagnosis and management of Type 1 diabetes in children and young people. Clinical guideline 15. London : National Institute for Clinical Excellence, 2004. Available at http://www.nice.org.uk Last accessed 1 April 2008.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
17. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria : R Foundation for Statistical Computing, 2007. Available at http://www.R-project.org Last accessed 1 April 2008.
18. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Consensus statement. Diabetes Care 2007 26 : 2194 2197.
19. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K. ISPAD clinical practice consensus guidelines. Microvascular and macrovascular complications. Pediatr Diabetes 2007 8 : 163 170.
20. Wennlöf AH, Yngve A, Nilsson TK, Sjöström M. Serum lipids, glucose and insulin levels in healthy schoolchildren aged 9 and 15 years from central Sweden: reference values in relation to biological, social and lifestyle factors. Scand J Clin Lab Invest 2005 65 : 65 76.
21. Austin A, Warty V, Janosky J, Arslanian S. The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM. Diabetes Care 1993 16 : 421 425.